Brain Stimulation for Dyslexia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to enhance reading skills in adults with dyslexia through non-invasive brain stimulation. Researchers aim to determine if this technique improves reading more effectively than traditional methods. The study compares various brain stimulation types, including CCN real non-invasive brain stimulation intervention, RLN and CCN real non-invasive brain stimulation intervention, and RLN real non-invasive brain stimulation intervention, alongside a sham version to assess real effects. Right-handed, native English-speaking adults who struggle with reading may qualify for this trial. As an unphased trial, it offers a unique chance to contribute to groundbreaking research that could transform dyslexia treatment.
Will I have to stop taking my current medications?
The trial excludes participants who are taking psychotropic medications or medications known to increase the risk of seizures or strokes. If you are on such medications, you may need to stop taking them to participate.
What prior data suggests that this non-invasive brain stimulation protocol is safe for adults with dyslexia?
Research has shown that non-invasive brain stimulation, such as transcranial direct current stimulation (tDCS), is generally safe. In studies involving 745 children and teens across 35 trials, no serious side effects occurred during 6,587 sessions, indicating that the treatment is usually well-tolerated.
For both the RLN and CCN brain stimulation methods, past research has found positive effects on brain functions related to reading and language skills. These benefits include fewer epileptic seizures and improvements in balance and math skills. Additionally, transcranial random noise stimulation (tRNS) has demonstrated stronger effects than tDCS on language and learning abilities.
Overall, while this specific trial is new, evidence from other studies suggests these brain stimulation methods are safe for people.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for dyslexia because they use non-invasive brain stimulation, a method that directly targets specific brain areas involved in reading and language processing. Unlike traditional dyslexia interventions, which often focus on behavioral therapies and educational strategies, these treatments aim to enhance brain function through stimulation of the left dorsolateral prefrontal cortex and left angular gyrus. This approach has the potential to improve reading skills by directly modifying neural activity, offering a novel avenue for intervention. Additionally, the use of real versus sham stimulation allows for precise measurement of the treatment's effectiveness, potentially leading to faster and more targeted improvements in dyslexia management.
What evidence suggests that this trial's brain stimulation treatments could be effective for dyslexia?
Research has shown that non-invasive brain stimulation can help people with dyslexia improve their reading skills. In this trial, participants will receive different types of brain stimulation. The RLN and CCN brain stimulation methods, part of separate treatment arms in this trial, target brain areas involved in reading. Studies indicate that combining methods like transcranial direct current stimulation (tDCS) with reading exercises can enhance specific reading abilities, such as recognizing sounds in words. Additionally, tDCS has been linked to better reading speed and accuracy. Overall, these findings provide promising evidence that brain stimulation could be a useful tool for improving reading skills in individuals with dyslexia.13678
Who Is on the Research Team?
Katherine S. Aboud, PhD
Principal Investigator
Vanderbilt University
Are You a Good Fit for This Trial?
This trial is for right-handed, native English-speaking adults aged 18-40 with dyslexia. Participants must not have a low IQ, developmental disorders, visual or hearing impairments that can't be corrected, metal devices in their body, recent migraines, severe fatigue or psychiatric issues. They should not be pregnant and mustn't take certain medications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Establish baseline behavior and brain measures of the individual
Intervention
Behavioral and non-invasive stimulation intervention, including MRI and EEG sessions
Follow-up Assessment
Establish prolonged intervention effects using behavior and brain measures
Long-term Follow-up
Participants are monitored for changes in reading comprehension and brain activations
What Are the Treatments Tested in This Trial?
Interventions
- CCN real non-invasive brain stimulation intervention
- RLN and CCN real non-invasive brain stimulation intervention
- RLN real non-invasive brain stimulation intervention
- Sham intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator